CD274 and lung cancer: Currently, immunotherapy is widely used in multiple cancers including lung cancer, and the multiple biomarkers related to the efficacy of ICI treatment have recently emerged, such as PD-L1 expression in tumor and/or immune cells and tumor mutation burden (5, 24, 25).